Clinverse, a global technology and eclinical commerce network for clinical trials, has formed a strategic partnership with OmniComm Systems, a provider of EDC solutions.

Clinverse’s ClinPay solution automates sponsor payments to clinical vendors, investigators and other parties throughout the entire financial lifecycle of a clinical trial. OmniComm’s TrialMaster EDC suite automates data collection and data validation and offers centralized monitoring with auto-redaction and automated SDTM export utility, allowing for efficient and cost-effective trial management.

The combined solution automatically evaluates study data within the EDC system against contract criteria and directly generates financial transactions and all related accounting information. This combination optimizes cost savings by streamlining an inherently error-prone manual process and substantially reduces the labor costs associated with the payment and accounting process for clinical vendors and investigative sites.

“OmniComm’s global footprint expands Clinverse’s reach to a broader international audience of pharmaceutical and biotech companies, CROs, research and medical device organizations that can greatly benefit from automated payment capabilities in conjunction with their EDC services,” said Steve Ayala, Clinverse president and head of strategic partnerships.

Clinverse’s open application programming interface (API) allows for seamless integration with existing systems such as OmniComm’s TrialMaster suite, as well as other external eclinical data sources such as CTMS, IxRS, ERP systems and data warehouses. When integrated with OmniComm’s TrialMaster EDC, direct financial transaction data feeds are automatically routed through the appropriate channels, resulting in consistent and timely payments, whether by procedure, visit or any other contracted term.